CBD Drug Co. Alleges Teva, Others Violated Patents
British pharmaceutical firm GW Pharmaceuticals has accused a dozen drug manufacturers, including Teva Pharmaceuticals, of violating its patents when they sought approval to sell generic versions of the company's flagship CBD-derived...To view the full article, register now.
Already a subscriber? Click here to view full article